ERK inhibitors were found to reverse the pro-aggressive effects of IL-6 in all HNSCC cell lines tested, regardless of HPV status (Figure 3C–F and Figure S3B–E). The gene discussed is IL6; the disease is head and neck squamous cell carcinoma.